GLP-1 and PCOS: A Complete Guide to Treatment Options

If you're one of the millions of women living with polycystic ovary syndrome (PCOS), you know how frustrating it can be to manage symptoms like weight gain, irregular periods, and metabolic issues. The condition affects up to 10% of women of reproductive age, yet treatment options have historically been limited. Now, GLP-1 medications are emerging as a promising tool that addresses several root causes of PCOS, particularly insulin resistance and weight management.

Let's explore what the science tells us about using GLP-1 therapy for PCOS and whether it might be right for you.

Understanding PCOS and Its Metabolic Roots

PCOS is more than just a reproductive condition. It's a complex metabolic and hormonal disorder that affects multiple body systems.

Women with PCOS often experience insulin resistance, meaning their bodies need more insulin to process glucose effectively. This excess insulin triggers the ovaries to produce more androgens like testosterone, which leads to many classic PCOS symptoms: irregular or absent periods, difficulty conceiving, acne, excess facial or body hair, and weight gain that's particularly stubborn around the midsection.

Up to 70% of women with PCOS have insulin resistance, regardless of their weight. This makes them more vulnerable to developing type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease over time.

Traditional PCOS treatments have included birth control pills to regulate periods, metformin to address insulin resistance, and anti-androgen medications. While these can help, they don't always address the full picture, especially when weight management is challenging.

How GLP-1 Medications Work

GLP-1 (glucagon-like peptide-1) medications were originally developed for type 2 diabetes but have shown remarkable benefits for weight management and metabolic health.

These medications mimic a natural hormone your gut produces after eating. GLP-1 slows digestion, reduces appetite, helps your pancreas release the right amount of insulin, and signals to your brain that you're full. The result is better blood sugar control and meaningful weight loss for many people.

Common GLP-1 medications include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Tirzepatide actually works on both GLP-1 and GIP receptors, which may make it even more effective for weight loss and metabolic improvements.

The Connection Between GLP-1 and PCOS

Because GLP-1 medications address insulin resistance and support weight loss, they target two major underlying drivers of PCOS symptoms.

Improved Insulin Sensitivity

Studies show that GLP-1 medications significantly improve insulin sensitivity in women with PCOS. When insulin levels normalize, the ovaries produce less testosterone, which can reduce symptoms like excess hair growth and acne.

One study found that liraglutide (another GLP-1 medication) reduced insulin resistance markers more effectively than metformin alone in women with PCOS.

Weight Loss Benefits

Weight management is often one of the most challenging aspects of PCOS. The hormonal imbalances make losing weight harder, yet even modest weight loss of 5-10% can dramatically improve PCOS symptoms.

Clinical trials show that GLP-1 medications help people lose 15-20% of their body weight on average. For women with PCOS, this weight loss can restore regular menstrual cycles, improve fertility, and reduce cardiovascular risk factors.

Menstrual Cycle and Fertility Improvements

Multiple studies have documented that women with PCOS who use GLP-1 medications often see improvements in menstrual regularity and ovulation rates.

A 2024 review found that GLP-1 therapy helped restore ovulation in women with PCOS who weren't ovulating regularly. This happened even in women who didn't lose significant weight, suggesting GLP-1 may have direct effects on ovarian function beyond just weight loss.

Reduced Androgen Levels

Research indicates that GLP-1 medications can lower testosterone and other androgen levels in women with PCOS. This means potential improvements in acne, excess hair growth, and male-pattern hair loss that many women experience.

What the Research Shows

While GLP-1 medications aren't yet FDA-approved specifically for PCOS, the evidence supporting their use continues to grow.

A 2023 study comparing semaglutide to lifestyle changes alone found that women with PCOS taking semaglutide lost significantly more weight and had greater improvements in metabolic markers, menstrual regularity, and quality of life.

Another study looking at tirzepatide showed even more impressive results, with participants losing an average of 20-25% of their body weight and seeing substantial improvements in insulin resistance and hormonal balance.

Most research has focused on women, as PCOS primarily affects female reproductive health. However, the metabolic benefits of GLP-1 therapy apply equally to men dealing with insulin resistance and weight management challenges.

Is GLP-1 Therapy Right for Your PCOS?

GLP-1 medications may be particularly beneficial if you have PCOS and:

• Struggle with insulin resistance or prediabetes
• Have difficulty losing weight despite diet and exercise efforts
• Experience irregular or absent menstrual cycles
• Are trying to conceive but not ovulating regularly
• Have metabolic syndrome or cardiovascular risk factors

These medications work best as part of a comprehensive approach that includes nutritional support, regular movement, stress management, and appropriate monitoring by healthcare providers familiar with both PCOS and metabolic health.

Important Considerations for Women

If you're trying to conceive, it's important to know that GLP-1 medications should be discontinued at least two months before attempting pregnancy. While weight loss and improved metabolic health can boost fertility in women with PCOS, these medications haven't been studied in pregnant women.

Additionally, if fertility improves on GLP-1 therapy and you're not planning pregnancy, reliable contraception becomes especially important.

What to Expect When Starting GLP-1 for PCOS

Most people start with a low dose that gradually increases over several weeks to minimize side effects like nausea, which typically improve with time.

You might notice appetite changes within the first few weeks, with weight loss typically becoming evident within the first month. Improvements in menstrual regularity may take two to three months, while metabolic markers like insulin sensitivity often improve within the first few months of treatment.

Regular monitoring of your symptoms, weight, menstrual patterns, and metabolic markers helps your healthcare provider adjust your treatment plan as needed.

From the Ozari Care Team

Our clinical experience shows that women with PCOS often see the best results when they pair GLP-1 therapy with a lower-carbohydrate eating pattern that further supports insulin sensitivity. We also recommend working with your healthcare team to monitor vitamin D and B12 levels, as deficiencies in these nutrients are common with PCOS and may need supplementation during treatment.

Taking the Next Step

If you're living with PCOS and struggling with weight, insulin resistance, or metabolic health concerns, GLP-1 medications may offer a new path forward. The growing body of research suggests these medications address root causes rather than just masking symptoms.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026